FDA approves first prescription oral medicine to treat iron deficiency in children

Iron deficiency affects many children and teenagers, often without noticeable symptoms. Tiredness, pale skin, and poor focus are easy to miss or blame on busy school days. The US FDA has now approved Accrufer, a prescription oral medicine, for children aged 10 years and older with iron deficiency. This step matters because it offers a new, non-invasive treatment option that fits better into daily life.

What exactly did the FDA approve?

The FDA approved Accrufer (ferric maltol) capsules for pediatric patients aged 10 and above who have iron deficiency. Until now, Accrufer was approved only for adults, starting in 2019.

This approval means doctors can legally prescribe this oral iron medicine to older children and teenagers who need medical treatment, not just dietary advice or supplements.

Why iron deficiency needs careful treatment

Iron deficiency is the most common cause of anemia. When iron levels drop, the body cannot make enough hemoglobin, the protein that carries oxygen in the blood.

In children, this can affect energy levels, growth, learning, and daily comfort. Common causes include poor iron absorption, blood loss, heavy menstruation in teens, or low iron intake over time.

What the clinical trial showed

The FDA decision was based on the FORTIS trial, which studied 24 patients aged 10-17 years.

Children received age-based doses of Accrufer twice daily. After 12 weeks, hemoglobin levels rose by an average of 1.1 g/dL.

This increase is considered clinically meaningful and is similar to what doctors expect from one blood transfusion, but without needles or hospital stays.

Safety facts parents should know

Accrufer is not for everyone. Children should not take it if they:

Have iron overload conditions like hemochromatosis

Receive repeated blood transfusions

Are allergic to its ingredients

Are having an inflammatory bowel disease flare

Common side effects include stomach discomfort, constipation or diarrhea, gas, nausea, vomiting, and darker stools. These effects are known and monitored by doctors.

This approval gives families and doctors a prescription-grade oral option backed by clinical data. It reduces dependence on injections or transfusions in suitable cases.

For school-going children, a capsule taken at home can mean fewer hospital visits, less anxiety, and steadier recovery. It also signals growing attention to pediatric nutrition-related conditions, which are often under-treated.

Disclaimer: This article is for informational purposes only. It does not replace medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting or changing any medication.